Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salmeterol Improves Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients

NCT01271556 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT01271556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01271556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salmeterol Improves Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients
Lead sponsor
University of Milan
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2008
Completion date
July 31, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchodilator agents, chronic obstructive pulmonary disease, salmeterol, salmeterol effect against an acute alveolar fluid clearance challenge secondary to lung fluid overload in copd patients